Be in the know. 10 key reads for Saturday…

  1. Negotiated drug prices will only apply to a narrow category of expensive drugs with no generic competition, and then only in relatively small numbers. (washingtonpost)
  2. Alibaba Chairman and CEO’s Letter to Shareholders (alibabagroup)
  3. SEC added Alibaba Group Holding Ltd. to a list of Chinese companies at risk of being delisted from the U.S. exchanges if their auditors can’t be inspected before spring 2024. (wsj)
  4. Amazon stock surges toward biggest monthly gain in 15 years (marketwatch)
  5. Billionaire investor Ray Dalio warns US can’t keep spending and bring down inflation (foxbusiness)
  6. Shale Drilling Climbs to Levels Not Seen Since Early Weeks of Pandemic (bloomberg)
  7. Intel’s Gelsinger Says Stock Deserves to Be Down, Rebound Coming (bloomberg)
  8. China Evergrande Breaks Silence on Debt-Restructuring Plan (wsj)
  9. Carried-Interest Change Would Hit Top Wall Street Brass, but Could Be Hard to Make Stick (wsj)
  10. What Did Joe Manchin Get for $433 Billion? (wsj)